Guardant Health
GH
#3260
Rank
NZ$6.12 B
Marketcap
$49.60
Share price
-3.64%
Change (1 day)
32.33%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of September 2024 : -NZ$0.11 Billion

According to Guardant Health 's latest financial reports the company has -NZ$0.11 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$0.25 B164.72%
2022-12-31$NZ$94.78 M-89.96%
2021-12-31$NZ$0.94 B-49.74%
2020-12-31$NZ$1.87 B49.21%
2019-12-31$NZ$1.25 B60.89%
2018-12-31$NZ$0.78 B80.1%
2017-12-31$NZ$0.43 B277.68%
2016-12-31$NZ$0.11 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$1.42 B-1,491.97%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.34 B-5,316.97%๐Ÿ‡บ๐Ÿ‡ธ USA